- Home
- GCV vs ICCM Comparison
GCV vs ICCM Comparison
Compare GCV & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- ICCM
- Stock Information
- Founded
- GCV 1988
- ICCM 2006
- Country
- GCV United States
- ICCM Israel
- Employees
- GCV N/A
- ICCM N/A
- Industry
- GCV Finance/Investors Services
- ICCM
- Sector
- GCV Finance
- ICCM
- Exchange
- GCV Nasdaq
- ICCM Nasdaq
- Market Cap
- GCV 75.6M
- ICCM 70.1M
- IPO Year
- GCV N/A
- ICCM N/A
- Fundamental
- Price
- GCV $3.59
- ICCM $1.03
- Analyst Decision
- GCV
- ICCM Strong Buy
- Analyst Count
- GCV 0
- ICCM 1
- Target Price
- GCV N/A
- ICCM $2.50
- AVG Volume (30 Days)
- GCV 57.9K
- ICCM 203.6K
- Earning Date
- GCV 01-01-0001
- ICCM 05-27-2025
- Dividend Yield
- GCV 13.04%
- ICCM N/A
- EPS Growth
- GCV N/A
- ICCM N/A
- EPS
- GCV N/A
- ICCM N/A
- Revenue
- GCV N/A
- ICCM $3,291,000.00
- Revenue This Year
- GCV N/A
- ICCM $97.02
- Revenue Next Year
- GCV N/A
- ICCM $212.86
- P/E Ratio
- GCV N/A
- ICCM N/A
- Revenue Growth
- GCV N/A
- ICCM 1.92
- 52 Week Low
- GCV $3.15
- ICCM $0.48
- 52 Week High
- GCV $4.58
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- GCV 54.26
- ICCM 37.29
- Support Level
- GCV $3.53
- ICCM $1.00
- Resistance Level
- GCV $3.59
- ICCM $1.10
- Average True Range (ATR)
- GCV 0.07
- ICCM 0.08
- MACD
- GCV 0.02
- ICCM -0.01
- Stochastic Oscillator
- GCV 87.50
- ICCM 8.82
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.